This bidirectional regulatory pattern was particularly evident in STAT1 and IRF3 downstream signatures, further supporting the hypothesis that CCRL2 serves as a key modulator of innate immune gene programs in melanoma cells. This evidence concerns the gene IRF3 and melanoma.